BDBM72988 MLS001083232::SMR000671833::[3-(3,4-difluoroanilino)-1-piperidinyl]-(6-quinoxalinyl)methanone::[3-(3,4-difluoroanilino)piperidin-1-yl]-quinoxalin-6-ylmethanone::[3-(3,4-difluoroanilino)piperidino]-quinoxalin-6-yl-methanone::[3-[[3,4-bis(fluoranyl)phenyl]amino]piperidin-1-yl]-quinoxalin-6-yl-methanone::cid_24790669

SMILES CC(C)(C)[C@H](NS(C)(=O)=O)C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)N[C@H](C#N)CC1C(=O)Nc3ccccc31)C2(C)C

InChI Key InChIKey=ZQYGZUFZGSYPRH-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 72988   

TargetReplicase polyprotein 1ab(2019-nCoV)
Trawsfynydd Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 72988BDBM72988((1S,2S,5S)-N-[(1S)-1-cyano-2-(2-oxoindolin-3-yl)et...)
Affinity DataIC50: 10nMAssay Description:Keywords: Heat Shock Factor-1 (HSF-1), Stress Response, MG132, NIH3T3, Luminescence Assay Overview: Modified NIH3T3, transformed to express firefly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/22/2026
Entry Details
US Patent